11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores
- Contribution to journal › Article
- 2017
-
Mark
Rare variant, gene-based association study of hereditary melanoma using whole-exome sequencing
- Contribution to journal › Article
-
Mark
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
- Contribution to journal › Article
-
Mark
Local Treatment of Unresectable Colorectal Liver Metastases : Results of a Randomized Phase II Trial
- Contribution to journal › Article
- 2016
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
- Contribution to journal › Article
-
Mark
Family History and Probability of Prostate Cancer, Differentiated by Risk Category : A Nationwide Population-Based Study
- Contribution to journal › Article
- 2011
-
Mark
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection
- Contribution to journal › Article
- 2008
-
Mark
Endogenous sex hormones and prostate cancer : A collaborative analysis of 18 prospective studies
- Contribution to journal › Article
- 2000
-
Mark
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
- Contribution to journal › Article
- 1999
-
Mark
Cancer risks in BRCA2 mutation carriers
- Contribution to journal › Article
